Cigna Group $CI Stock Holdings Increased by Vinva Investment Management Ltd

Vinva Investment Management Ltd boosted its stake in shares of Cigna Group (NYSE:CI) by 31.7% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,868 shares of the health services provider’s stock after purchasing an additional 4,540 shares during the period. Vinva Investment Management Ltd’s holdings in Cigna Group were worth $6,157,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CI. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. LPL Financial LLC grew its stake in Cigna Group by 14.1% in the first quarter. LPL Financial LLC now owns 207,026 shares of the health services provider’s stock valued at $68,111,000 after purchasing an additional 25,588 shares in the last quarter. Prosperity Consulting Group LLC acquired a new position in Cigna Group in the 1st quarter worth about $219,000. Foundations Investment Advisors LLC increased its position in Cigna Group by 25.7% in the 1st quarter. Foundations Investment Advisors LLC now owns 2,824 shares of the health services provider’s stock worth $929,000 after purchasing an additional 578 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new stake in shares of Cigna Group during the 1st quarter worth about $510,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Cantor Fitzgerald lowered their price target on Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Wolfe Research dropped their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Finally, Morgan Stanley restated an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $334.05.

Insider Transactions at Cigna Group

In other news, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Cigna Group Stock Up 0.1%

CI opened at $278.60 on Friday. The business has a 50 day moving average of $285.25 and a 200-day moving average of $297.60. The stock has a market capitalization of $74.42 billion, a price-to-earnings ratio of 15.21, a P/E/G ratio of 0.88 and a beta of 0.44. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same quarter in the previous year, the firm posted $7.51 earnings per share. Cigna Group’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.